12:00 AM
 | 
Dec 03, 2007
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Neurimmune Therapeutics AG

Zurich, Switzerland

Technology: Reverse translational medicine

Disease focus: Neurology

Clinical...

Read the full 41 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >